tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY

Compare Alnylam Pharma (ALNY) vs. Competitors

Compare
1,356 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$398.82
$52.92B
1,666.35
68.98%
17 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$99.29
$19.65B
16.79
45.12%
9 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$459.78
$117.45B
32.62
15.13%
16 Buy
6 Hold
0 Sell
Moderate Buy
Argenx Se
$837.45
$52.14B
39.69
35.08%
17 Buy
3 Hold
0 Sell
Strong Buy
Genmab
$32.52
$20.63B
14.08
56.57%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$94.52
$22.73B
-35.93
-15.44%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALNY
Alnylam Pharma
398.82
162.81
68.98%
INCY
Incyte
99.29
30.87
45.12%
VRTX
Vertex Pharmaceuticals
459.78
60.43
15.13%
ARGX
Argenx Se
837.45
217.49
35.08%
GMAB
Genmab
32.52
11.75
56.57%
BNTX
BioNTech SE
95.20
-17.38
-15.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts